Replicate Bioscience, Inc.
Self-replicating RNA (srRNA) technology platform for therapeutic development
- Sector
- Biotech
- Headquarters
- SAN DIEGO, CA
- Founded
- 2021
- Latest Form D
- $6M, Feb 2021
- Total capital
- $6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $6M
- 1 Form D · last Feb 2021
- 68 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 37 pending · first 2022
- Rank in peer group#339 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#339 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Joseph YanchikDirectorNamed in SEC Form D filings
- Michael EhlersExecutive Officer, DirectorNamed in SEC Form D filings
- Nathaniel WangExecutive Officer, DirectorNamed in SEC Form D filings
- Seth HarrisonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 40- PendingModified Madariaga Viruses, Self-replicating Rna Constructs, And Uses ThereofUSPTOApplication 19132604
- PendingModified Western Equine Encephalitis Viruses And Uses ThereofUSPTOApplication 18858163
- PendingCompositions And Methods For The Prevention And Treatment Of Rabies Virus InfectionUSPTOApplication 18856455
Show all 40 patent records
- Modified Madariaga Viruses, Self-replicating Rna Constructs, And Uses ThereofJul 30, 2026 · Application 19132604Pending
- Modified Western Equine Encephalitis Viruses And Uses ThereofAug 14, 2025 · Application 18858163Pending
- Compositions And Methods For The Prevention And Treatment Of Rabies Virus InfectionJun 12, 2025 · Application 18856455Pending
- Methods For Generating Functional Self-replicating Rna MoleculesMay 8, 2025 · Application 18833620Pending
- Compositions And Methods For Expression Of IL-12 And IL-1RAJan 23, 2025 · Application 18713851Pending
- Compositions And Methods For Inducing ESR1, PI3K, HER2, And HER3 Immune ResponsesJan 23, 2025 · Application 18713901Pending
- Methods Of Generating Self-replicating Rna MoleculesJan 16, 2025 · Application 18714038Pending
- Modified Alphaviruses With Heterologous Nonstructural ProteinsDec 5, 2024 · Application 18688697Pending
- Modified Eastern Equine Encephalitis Viruses, Self-replicating Rna Constructs, And Uses ThereofOct 3, 2024 · Application 18577545Pending
- Alphavirus Vectors Containing Universal Cloning AdaptorsJul 4, 2024 · Application 18555852Pending
- Compositions And Methods For Expression Of IL-12 And IL-1RAJan 16, 2024 · US 11,873,507Granted
- Modified Chikungunya Viruses And Sindbis Viruses And Uses ThereofDec 14, 2023 · Application 18007036Pending
- Compositions And Methods For The Prevention And Treatment Of Rabies Virus InfectionAug 22, 2023 · US 11,730,804Granted
- Compositions And Methods For Inducing ESR1, PI3K, HER2, And HER3 Immune ResponsesNov 29, 2022 · US 11,510,975Granted
- Modified Madariaga Viruses, Self-replicating Rna Constructs, And Uses ThereofApplication 63385556Pending
- Compositions And Methods For Expression Of IL-12 And IL-1RAApplication PCTUS2022080521Pending
- Compositions And Methods For Inducing ESR1, PI3K, HER2, And HER3 Immune ResponsesApplication PCTUS2022080522Pending
- Methods Of Generating Self-replicating Rna MoleculesApplication PCTUS2022080515Pending
- Modified Alphaviruses With Heterologous Nonstructural ProteinsApplication PCTUS2022075853Pending
- Modified Eastern Equine Encephalitis Viruses, Self-replicating Rna Constructs, And Uses ThereofApplication PCTUS2022073563Pending
- Alphavirus Vectors Containing Universal Cloning AdaptorsApplication PCTUS2022025470Pending
- Modified Western Equine Encephalitis Viruses And Uses ThereofApplication 63332606Pending
- Methods For Generating Functional Self-replicating Rna MoleculesApplication 63303886Pending
- Methods Of Generating Self-replicating Rna MoleculesApplication 63283660Pending
- Modified Alphaviruses With Heterologous Nonstructural ProteinsApplication 63240297Pending
- Modified Chikungunya Viruses And Sindbis Viruses And Uses ThereofApplication PCTUS2021043991Pending
- Modified Eastern Equine Encephalitis Viruses And Uses ThereofApplication 63220139Pending
- Alphavirus Vectors Containing Universal Cloning AdaptorsApplication 63177656Pending
- Modified Chikungunya Viruses And Sindbis Viruses And Uses ThereofApplication 63059777Pending
- Methods For Identification And Selection Of Self-replicating Rna Molecules For Biomedical ApplicationsApplication 19484464Pending
- Compositions And Methods For Inducing Immune Response Against Epstein-barr VirusesApplication 19601379Pending
- Compositions And Methods For Expression Of IL-1RA And IL-18BPApplication 19486593Pending
- Compositions And Methods For Expression Of GLP-1 Receptor AgonistsApplication PCTUS2026010741Pending
- Compositions And Methods For Expression Of EgfrApplication 19581733Pending
- Compositions And Methods For Expression Of GLP-1 Receptor AgonistsApplication 63744134Pending
- Compositions And Methods For Inducing Immune Response Against Epstein-barr VirusesApplication PCTUS2024061315Pending
- Compositions And Methods For Expression Of EgfrApplication PCTUS2024052996Pending
- Compositions And Methods For Expression Of IL-1RA And IL-18BPApplication PCTUS2024030802Pending
- Methods For Identification And Selection Of Self-replicating Rna Molecules For Biomedical ApplicationsApplication PCTUS2024029444Pending
- Compositions And Methods For Inducing Immune Response Against Epstein-barr VirusesApplication 63615206Pending
Related companies, and why
- ZY THERAPEUTICS INC.Similar federal contract value in Biotech · null in contracts
- Reprogram Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Cynaptec Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Amicrobe, Inc.Similar federal contract value in Biotech · null in contracts
- NurExone Biologic Inc.Similar federal contract value in Biotech · null in contracts
- Beta Cat Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .